To identify potential therapeutic targets of those cancers and immune escape, we have collected more than forty representative immune checkpoint genes, including BTLA, CD200, TNFRSF14, NRP1, LAIR1 and so on, and we evaluated the relationship between expression of COL1A1 and immune checkpoint. This evidence concerns the gene COL1A1 and cancer.